These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9258223)

  • 1. Uveal melanoma. Growth rate and prognosis.
    Char DH; Kroll S; Phillips TL
    Arch Ophthalmol; 1997 Aug; 115(8):1014-8. PubMed ID: 9258223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irradiated uveal melanomas: cytopathologic correlation with prognosis.
    Char DH; Kroll SM; Miller T; Castro J; Quivey J
    Am J Ophthalmol; 1996 Oct; 122(4):509-13. PubMed ID: 8862047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
    Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
    J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy.
    Demirci H; Saponara F; Khan A; Niziol LM; Lee C; Hayman JA; Comer G; Musch DC
    Middle East Afr J Ophthalmol; 2015; 22(1):103-7. PubMed ID: 25624683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine Plaque Brachytherapy a Customized Conservative Approach to the Management of Medium/Large-sized Uveal Melanoma.
    Laliscia C; Perrone F; Cresti F; Guido F; Fuentes T; Trippa C; Paiar F; Pellegrini G; Ebert FG
    In Vivo; 2024; 38(4):1814-1822. PubMed ID: 38936895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.
    Quivey JM; Augsburger J; Snelling L; Brady LW
    Cancer; 1996 Jun; 77(11):2356-62. PubMed ID: 8635107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
    Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.
    Badiyan SN; Rao RC; Apicelli AJ; Acharya S; Verma V; Garsa AA; DeWees T; Speirs CK; Garcia-Ramirez J; Esthappan J; Grigsby PW; Harbour JW
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):801-5. PubMed ID: 24462385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit.
    Sánchez-Tabernero S; García-Alvarez C; Muñoz-Moreno MF; Diezhandino P; Alonso-Martínez P; de Frutos-Baraja JM; López-Lara F; Saornil MA
    Am J Ophthalmol; 2017 Aug; 180():39-45. PubMed ID: 28572063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
    Mishra KK; Quivey JM; Daftari IK; Weinberg V; Cole TB; Patel K; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):376-83. PubMed ID: 25841624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
    King B; Morales-Tirado VM; Wynn HG; Gao BT; Ballo MT; Wilson MW
    Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma.
    Harbour JW; Char DH; Kroll S; Quivey JM; Castro J
    Ophthalmology; 1997 Nov; 104(11):1785-92; discussion 1792-3. PubMed ID: 9373108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible effects of radiobiological parameters on metastatic spread of uveal melanomas treated with 106Ru plaques.
    Kleineidam M; Guthoff R
    Ger J Ophthalmol; 1994 Jan; 3(1):22-5; discussion 25-6. PubMed ID: 8142877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling and regression rate of irradiated uveal melanomas.
    Rao RC; Khan M; Badiyan SN; Harbour JW
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):333-7. PubMed ID: 25856819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.
    Eskelin S; Pyrhönen S; Summanen P; Hahka-Kemppinen M; Kivelä T
    Ophthalmology; 2000 Aug; 107(8):1443-9. PubMed ID: 10919885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of melanoma cell type in uveal melanoma following treatment failure.
    Char DH; Miller T; Crawford JB
    Am J Ophthalmol; 2004 Oct; 138(4):543-6. PubMed ID: 15488778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.